BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25375241)

  • 21. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.
    Syljuåsen RG; Sørensen CS; Hansen LT; Fugger K; Lundin C; Johansson F; Helleday T; Sehested M; Lukas J; Bartek J
    Mol Cell Biol; 2005 May; 25(9):3553-62. PubMed ID: 15831461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress.
    Kim SH; Park ER; Joo HY; Shen YN; Hong SH; Kim CH; Singh R; Lee KH; Shin HJ
    Cancer Lett; 2014 May; 346(2):249-56. PubMed ID: 24434653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDC1 is a mediator of the mammalian DNA damage checkpoint.
    Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
    Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.
    Gagou ME; Zuazua-Villar P; Meuth M
    Mol Biol Cell; 2010 Mar; 21(5):739-52. PubMed ID: 20053681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors.
    Goss KL; Koppenhafer SL; Waters T; Terry WW; Wen KK; Wu M; Ostergaard J; Gordon PM; Gordon DJ
    Oncogene; 2021 Jan; 40(3):564-577. PubMed ID: 33191406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential Roles of Ribonucleotide Reductases under DNA Damage and Replication Stresses in Cryptococcus neoformans.
    Jung KW; Kwon S; Jung JH; Bahn YS
    Microbiol Spectr; 2022 Aug; 10(4):e0104422. PubMed ID: 35736239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the mevalonate pathway induces dNTP depletion and DNA damage.
    Martín Sánchez C; Pérez Martín JM; Jin JS; Dávalos A; Zhang W; de la Peña G; Martínez-Botas J; Rodríguez-Acebes S; Suárez Y; Hazen MJ; Gómez-Coronado D; Busto R; Cheng YC; Lasunción MA
    Biochim Biophys Acta; 2015 Sep; 1851(9):1240-53. PubMed ID: 26055626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess ribonucleotide reductase R2 subunits coordinate the S phase checkpoint to facilitate DNA damage repair and recovery from replication stress.
    Lin ZP; Belcourt MF; Carbone R; Eaton JS; Penketh PG; Shadel GS; Cory JG; Sartorelli AC
    Biochem Pharmacol; 2007 Mar; 73(6):760-72. PubMed ID: 17188250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
    Chen G; Luo Y; Warncke K; Sun Y; Yu DS; Fu H; Behera M; Ramalingam SS; Doetsch PW; Duong DM; Lammers M; Curran WJ; Deng X
    Nat Commun; 2019 Jul; 10(1):3213. PubMed ID: 31324785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.
    D'Angiolella V; Donato V; Forrester FM; Jeong YT; Pellacani C; Kudo Y; Saraf A; Florens L; Washburn MP; Pagano M
    Cell; 2012 May; 149(5):1023-34. PubMed ID: 22632967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer.
    Wu L; Yin L; Ma L; Yang J; Yang F; Sun B; Nianzeng X
    Aging (Albany NY); 2022 Oct; 14(19):7890-7905. PubMed ID: 36202136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease.
    Altinkilic EM; Isbir S; Gormus U; Yilmaz SG; Dalan AB; Duman S; Isbir T
    In Vivo; 2016 09-10; 30(5):611-5. PubMed ID: 27566080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation.
    Ewald B; Sampath D; Plunkett W
    Mol Cancer Ther; 2007 Apr; 6(4):1239-48. PubMed ID: 17406032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
    Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
    Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
    An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
    BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.
    Håkansson P; Hofer A; Thelander L
    J Biol Chem; 2006 Mar; 281(12):7834-41. PubMed ID: 16436374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chk1 is essential for tumor cell viability following activation of the replication checkpoint.
    Cho SH; Toouli CD; Fujii GH; Crain C; Parry D
    Cell Cycle; 2005 Jan; 4(1):131-9. PubMed ID: 15539958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.
    Buisson R; Boisvert JL; Benes CH; Zou L
    Mol Cell; 2015 Sep; 59(6):1011-24. PubMed ID: 26365377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.